Eton Pharmaceuticals, Inc. (ETON) Corporate Subsidiaries
Eton Pharmaceuticals, Inc. (ETON) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ETON
CIK: 1710340
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJeffrey Pajauskas
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | FORM 8-K | 0001437749-26-032600 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-06 | FORM 4 | 0001437749-26-032240 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001974078-26-000377 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-28 | FORM 8-K | 0001437749-26-031281 | View SEC Doc Filr Page |
| 4/A | 2026-08-31 | 2026-08-28 | FORM 4/A | 0001437749-26-029308 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-28 | FORM 4 | 0001437749-26-029196 | View SEC Doc Filr Page |
| 144 | 2026-08-28 | — | 144 Filing | 0001974078-26-000335 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-24 | FORM 4 | 0001437749-26-028846 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001974078-26-000328 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | FORM 4 | 0001437749-26-028651 | View SEC Doc Filr Page |
| 144/A | 2026-08-20 | — | 144/A Filing | 0001974078-26-000322 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001974078-26-000315 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001437749-26-027684 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | FORM 8-K | 0001437749-26-027672 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-07-31 | PRIMARY DOCUMENT | 0001437749-26-027363 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-07-31 | FORM 8-K | 0001437749-26-025781 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001437749-26-025725 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001437749-26-025715 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001437749-26-025712 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001437749-26-025709 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001437749-26-025706 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001437749-26-025700 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001437749-26-025696 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001437749-26-025694 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-07-31 | FORM 8-K | 0001437749-26-025506 | View SEC Doc Filr Page |